MilliporeSigma and bluebird bio ink multi-year viral vector deal

By Flora Southey contact

- Last updated on GMT

GettyImages/AntonioGuillem
GettyImages/AntonioGuillem

Related tags: Viral vector, Dna, Gene therapy

Bluebird Bio has hired MilliporeSigma to supply lentiviral vectors for the development of gene therapies.

Under the commercial supply agreement, MilliporeSigma – the life science branch of Merck KGaA – will manufacture vectors for the Massachusetts, US-headquartered firm’s drug products, indicated to treat rare genetic diseases.

Merck told us the lentivrial vectors – which are used to deliver personalised gene therapies into immune cells – will be manufactured at its Carlsbad, California facility.

The firm recently expanded​ the gene therapy facility, which houses viral bulk manufacturing cleanrooms, fill/finish suites and viral vaccine and immunotherapy products.

Merck has expertise in the production of a wide variety of viral vectors used for gene therapy and viral vaccines, the spokesperson told us.

The firm “has a focus on quality in clinical and commercial supply as evidenced by our facility completing both a US Food and Drug Administration[FDA] Pre-License inspection and a European Medicines Agency [EMA] Marketing Authorization inspection,” ​he added.

Outsourcing relationships

A Merck spokesperson told us the firm has worked with bluebird bio “for some time on production of lentiviral vectors across all their programmes.”

In November last year, bluebird bio reaffirmed​ its commitment to its outsourcing partners, when it announced plans to buy a manufacturing facility in North Carolina but continue to work with contract manufacturers.

At the time, bluebird bio said the in-house lentiviral vector manufacturing facility would not disrupt multi-year contracts with firms including Brammer Bio, Novasep, and MilliporeSigma.  

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers